Results 211 to 220 of about 1,952,261 (305)

A Systematic Comparison of Alpha‐Synuclein Seed Amplification Assays for Increasing Reproducibility

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Seed amplification assays (SAAs) enable ultrasensitive detection of misfolded α‐synuclein across biofluids and tissues. Yet, heterogeneity in protocols limits cross‐study comparability and clinical translation. Here, we review α‐synuclein SAA methods and their performance across various biological matrices.
Manuela Amaral‐do‐Nascimento, Daniela F. Santos, Tuane C. R. G. Vieira, Tiago F. Outeiro   +3 more
wiley   +1 more source

Public-private mix in health systems and repercussions for health inequalities in Latin American countries: A scoping review protocol. [PDF]

PLoS One
Ferreira Dos Anjos E, Carlos de Oliveira S, Mendoza-Ruiz A, Flores-Quispe MDP, Mendes Pereira AM, Kendall C, Franco Sansigolo Kerr LR, Ortelan N, Pereira Pinto Junior E, Romero N, Leyland A, Barreto ML, Machado CV, Unit on the Social and, Environmental Determinants of Health Inequalities (SEDHI).   +14 more
europepmc   +1 more source

Prognostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in ALD‐Related Myelopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background X‐linked adrenoleukodystrophy (X‐ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1, leading to slowly progressive spinal cord disease in nearly all affected men. Sensitive biomarkers to quantify disease severity and predict progression are needed for clinical care and trial design.
Eda G. Kabak, Marije M. C. Voermans, Hans Heijst, Charlotte E. Teunissen, Marc Engelen   +4 more
wiley   +1 more source

Socioeconomic determinants of shift work employment in Canada and the Netherlands: a cross-sectional analysis of data from the Canadian Longitudinal Study on Aging and the Hoorn Study. [PDF]

Front Public Health
Campbell DB, Reed T, Slebe R, Raina P, Rutters F, Joshi D, de Mutsert R, Despres JP, Hoeks J, Blondin DP, Carpentier A, Schrauwen P, Campbell DJT.   +12 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

The mediating role of quality of life in the relationship between teachers' participation in physical activity and empathic and social self-efficacy. [PDF]

Front Psychol
Turhan MO, Arslanboga R, Eroglu SY, Koc MC, Carneiro L, Talaghir LG, Manolache GM, Iconomescu TM, Cristea F, Berdila A.   +9 more
europepmc   +1 more source

Philosophical Reflections on Research Methodology for Social Sciences

Beytulhikme An International Journal of Philosophy, 2019
openaire   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Global Evidence on Helmet Use and Misuse: A Public Health Perspective on Prevalence, Determinants and Barriers. [PDF]

Health Sci Rep
Rezapour R, Ghorbani R, Derakhshani N, Abedi L, Sayyadzadeh M, Saadati M.   +5 more
europepmc   +1 more source